NCT06613191View on ClinicalTrials.gov

Colonoscopy and Antiplatelet Therapy Trial

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Coronary Arterial Disease (CAD)Peripheral Vascular Disease
Interventions
DRUG

Aspirin

Participant will be on aspirin alone or P2Y12 inhibitor alone

DRUG

P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel)

Participant will be taking either P2Y12 inhibitor at time of colonoscopy

Trial Locations (1)

70121

Ochsner Health, New Orleans

Sponsors
All Listed Sponsors
lead

Ochsner Health System

OTHER